Invenio Wealth Partners LLC Purchases 372 Shares of UnitedHealth Group Incorporated $UNH

Invenio Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,936 shares of the healthcare conglomerate’s stock after buying an additional 372 shares during the quarter. Invenio Wealth Partners LLC’s holdings in UnitedHealth Group were worth $604,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of UNH. Vanguard Group Inc. lifted its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP lifted its stake in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after buying an additional 2,486,839 shares during the period. Geode Capital Management LLC grew its position in shares of UnitedHealth Group by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock worth $6,624,411,000 after buying an additional 675,075 shares during the period. Nuveen LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $3,846,764,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after purchasing an additional 847,054 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. Bank of America lifted their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 8th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. TD Cowen lifted their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a report on Thursday, October 30th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Finally, The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price target for the company. Eighteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Price Performance

NYSE:UNH opened at $320.59 on Tuesday. The stock’s 50-day simple moving average is $347.66 and its 200 day simple moving average is $318.23. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $622.83. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The company has a market cap of $290.40 billion, a P/E ratio of 16.73, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $7.15 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.